drug · small molecule
patient view →TAZAROTENE
Marketedupdated 2mo agoby $GRI GRI Bio, Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 3 investigational indications.
indications
investigational
Pulmonary Fibrosis
targets
Retinoic acid receptor
all catalysts(1)
approval · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that